Global qPCR Instruments Market Overview to 2028



DUBLIN, October 18, 2021 / PRNewswire / – The “qPCR Instruments Market Size, Share and Trend Analysis Report by Instrument (GeneXpert, BioFireFilmArray Systems, BMS Mic System), by Region (North America, Europe, APAC, LATAM, MEA), and the Segment Forecasts report, 2021-2028 “has been added to ResearchAndMarkets.com offer.

Research and Markets logo

The global qPCR instruments market size is expected to reach $ 1.39 billion by 2028, according to a new report from the publisher, it is expected to grow at a CAGR of 3.4% from 2021 to 2028. The market is driven by the introduction of advanced new products and increased demand for highly efficient diagnostic equipment.

The demand for qPCR instruments and consumables is driven by the increasing incidence of SARS-CoV-2 infections worldwide. The increased incidence is expected to increase the number of preventive screenings. This can be attributed to the fact that nations cannot determine the number of COVID-19 patients without screening them.

The miniaturization of three basic molecular tests is expected to increase the precision and specificity of diagnostic results and, therefore, increase the demand for molecular diagnostic products. These improvements are expected to improve the availability of POC molecular diagnostic assays to provide rapid and efficient test results. For example, the Mic qPCR system from Biomolecular Systems weighs only 2 kilograms, which makes the device very portable and easy to handle.

Recently launched products such as the QuantStudio 5 Dx Real-Time PCR System offer consumers improved workflows and high-volume testing to deliver faster results. Profitability and simplified software give it additional advantages. In addition, the approval of the instrument in more than 50 countries can help to strengthen the growth of the market. The instrument is also equipped with measurements for companion research diagnostics, giving it a competitive advantage.

The market is strongly threatened by external substitutes due to the presence of very advanced and more precise digital PCR instruments. The strong threat of internal substitution can be attributed to the presence of many products available in the market. However, the higher price of these instruments should reduce the overall threat, keeping it at a moderate level.

COVID-19 has increased the opportunities for diagnostic devices. However, advanced PCR technologies, such as dPCR, are more preferred in developed economies because they can help reduce false positive rates. Researching the development of effective qPCR instruments can reduce the threat of device substitution and improve market growth.

In recent years, PCR has seen technological advances in terms of sensitivity, precision, efficiency and cost-effectiveness. Key players introduce new technologies to maintain a competitive advantage.

Highlights of the qPCR Instruments Market Report

  • By Instrument, GeneXpert Segment Expected to Post Fastest CAGR from 2021 to 2028

  • Asia Pacific is expected to experience the fastest growth during the forecast period due to the increasing number of investments to improve diagnostic infrastructure and the increasing prevalence of infectious diseases

  • The unmet needs in the market are high. For example, the lack of affordable qPCR instruments prevents the market from reaching its full potential

  • Recently launched products such as the QuantStudio 5 Dx Real-Time PCR System offer consumers improved workflows and high-volume testing to deliver faster results. Cost-effectiveness and simplified software give it additional advantages

  • North America captured the largest share of revenue in 2020 and is expected to maintain its lead over the forecast period. Improved regulatory support and increased new product launches are expected to fuel market growth

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Variables, Trends and Scope of the qPCR Instruments Market
3.1 Lineage Outlook for qPCR Instruments Market
3.1.1 Parents’ Market Outlook
3.1.2 Related / Auxiliary Market Outlook
3.2 Regulatory and reimbursement framework
3.3 Market dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increased incidence of chronic diseases, infectious diseases and genetic disorders
3.3.1.2 Technological advances in PCR
3.3.1.3 Implementation of MIQE directives
3.3.1.4 Growing adoption of qPCR technologies
3.3.1.5 Increase in the number of CROs and forensic and research laboratories
3.3.1.6 Growing demand for prenatal genetic testing procedures
3.3.1.7 Increased demand for point-of-care diagnostics
3.3.2 Analysis of market restrictions
3.3.2.1 Presence of a strict regulatory framework
3.3.2.2 High prices of qPCR instruments
3.4 Porter’s five forces analysis
3.5 SWOT analysis; By factor (Political & Legal, Economic and Technological)
3.6 Analysis of major transactions and strategic alliances
3.6.1 Launch of new products
3.6.2 Mergers and acquisitions
3.6.3 Enlargement
3.6.4 Partnerships
3.7 Opportunity analysis for qPCR
3.7.1 unmet needs
3.7.2 Changing Market Dynamics After New Product Launch
3.7.3 Analysis of consumer behavior

Chapter 4 qPCR Instruments Market: Segment Analysis, by Instrument, 2017-2028 (USD Million)
4.1 Global qPCR Instruments Market, by Instrument, 2017-2028
4.2 Definition and scope
4.3 Market size and forecast and trend analysis, 2017 to 2028
4.3.1 Thermo Fisher Scientific, Inc.
4.3.1.1 7500
4.3.1.1.1 7500
4.3.1.1.2 7500 Fast
4.3.1.1.3 7500 Fast Dx
4.3.1.1.4 Market 7500, 2017 – 2028 (USD million)
4.3.1.2 QuantStudio Dx real-time PCR
4.3.1.2.1 Quantstudio Dx Market, 2017-2028 (USD Million)
4.3.1.3 QuantStudio 5 Dx real-time PCR
4.3.1.3.1 Quantstudio 5 DX Market, 2017-2028 (USD Million)
4.3.1.4 ViiA 7Dx
4.3.1.4.1 Vii A Dx Market, 2017-2028 (USD Million)
4.3.1.5 StepOne / StepOne Plus Real-Time PCR Systems
4.3.1.5.1 StepOne / StepOne Plus System Market, 2017-2028 (USD Million)
4.3.2 F. Hoffmann-La Roche Ltée.
4.3.2.1 LightCycler 2.0 / 96 / 480/1536
4.3.2.1.1 LightCycler 2.0 / 96 / 480/1536 Market, 2017-2028 (USD Million)
4.3.2.2 Cobas 4800
4.3.2.2.1 Cobas 4800 Market, 2017-2028 (USD Million)
4.3.3 Bio-Rad Laboratories, Inc.
4.3.3.1 CFX96
4.3.3.1.1 CFX 96 Market, 2017-2028 (USD Million)
4.3.4 Danaher Company
4.3.4.1 SmartCycler
4.3.4.1.1 SmartCycler Market, 2017-2028 (USD Million)
4.3.4.2 GeneXpert
4.3.4.2.1 GeneXpert Market, 2017-2028 (USD Million)
4.3.5 QIAGEN
4.3.5.1 Rotor-Gene Q
4.3.5.1.1 Gene Q Rotor Market, 2017-2028 (USD Million)
4.3.5.2 Rotor-Gene Q MDx 5plex HRM
4.3.5.2.1 Rotor Gene Q MDx 5plex HRM Market, 2017-2028 (USD Million)
4.3.6 bioMérieux SA
4.3.6.1 BioFire FlimArray Systems
4.3.6.1.1 BioFire FilmArray Systems Market, 2017-2028 (USD Million)
4.3.7 Biomolecular systems
4.3.7.1 BMS microphone system
4.3.7.1.1 BMS Mic qPCr System Market, 2017-2028 (USD Million)

Chapter 5 qPCR Instruments Market: Regional Market Analysis, 2017-2028 (USD Million)

Chapter 6 Competitive Landscape
6.1 Recent developments and impact analysis, by major market players
6.1.1 Ansoff matrix
6.2 Categorization of companies
6.2.1 Innovators
6.3 Supplier landscape
6.3.1 List of major distributors and distribution partners
6.3.2 Key Customers
6.4 Public enterprises
6.4.1 Analysis of the company’s position on the market
6.4.2 Competitive Dashboard Analysis
6.4.2.1 Market differentiators
6.5 Private companies
6.5.1 List of Main Emerging Companies
6.6 Company profiles
6.6.1 Thermo Fisher Scientific, inc.
6.6.1.1 Company overview
6.6.1.2 Financial performance
6.6.1.3 Product benchmarking
6.6.1.4 Strategic initiatives
6.6.2 F. Hoffmann-La Roche Ltée.
6.6.2.1 Company overview
6.6.2.2 Financial performance
6.6.2.3 Product Benchmarking
6.6.2.4 Strategic initiatives
6.6.3 Bio-Rad Laboratories, Inc.
6.6.3.1 Company overview
6.6.3.2 Financial performance
6.6.3.3 Product Benchmarking
6.6.3.4 Strategic initiatives
6.6.4 Danaher Company
6.6.4.1 Company overview
6.6.4.2 Cepheid
6.6.4.3 Beckman coulter
6.6.4.4 Financial performance
6.6.4.5 Product Benchmarking
6.6.5 Qiagen
6.6.5.1 Company overview
6.6.5.2 Financial performance
6.6.5.3 Product Benchmarking
6.6.5.4 Strategic initiatives
6.6.6 Agilent Technologies, Inc.
6.6.6.1 Company overview
6.6.6.2 Financial performance
6.6.6.3 Product Benchmarking
6.6.6.4 Strategic initiatives
6.6.7 Abbott
6.6.7.1 Company overview
6.6.7.2 Alere, Inc.
6.6.7.3 Financial performance
6.6.7.4 Product benchmarking
6.6.7.5 Strategic initiatives
6.6.8 bioMérieux SA
6.6.8.1 Company overview
6.6.8.2 Financial performance
6.6.8.3 Product Benchmarking
6.6.8.4 Strategic initiatives
6.6.9 Quantabio
6.6.9.1 Company overview
6.6.9.2 Product Benchmarking
6.6.9.3 Strategic initiatives
6.6.10 Azure Biosystems, Inc.
6.6.10.1 Company overview
6.6.10.2 Product Benchmarking
6.6.10.3 Strategic initiatives
6.6.11 Biomolecular systems
6.6.11.1 Company overview
6.6.11.2 Product Benchmarking
6.6.11.3 Strategic initiatives

For more information on this report, visit https://www.researchandmarkets.com/r/umnwp2

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/insights-on-the-qpcr-instruments-global-market-to-2028—by-instrument-and-region-301402298.html

SOURCE Research and Markets


Previous Animated film "Catwoman: Hunted" from DC and Warner Bros.
Next Triller will present "Triad Combat", combining elements of boxing and MMA